Cloverleaf Bio
Cloverleaf Bio is seeking an experienced RNA Biochemist to join their early‑stage therapeutics team. The role involves designing and executing low‑ and high‑throughput RNA screening assays, generating RNA‑seq libraries, and conducting mechanistic cell studies to develop novel RNA therapeutics for cancer and other disease areas.
Cloverleaf Bio is a biotechnology company developing a new class of RNA therapeutics to revolutionize cancer therapy. The company recently raised a $33M seed round to advance its pipeline. It is currently hiring and actively growing its team.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cloverleaf Bio.
Cloverleaf Bio didn’t post a salary, so this is our estimate from similar listings.
43% below the average for this role
Scientist I - RNA Therapeutic Discovery (4-month contract)
Ascidian Therapeutics
Principal Research Associate
Deep Genomics
Molecular Postdoctoral Position
mountsinaihospital.com
Research Fellow Lab Medicine And Pathology Rochester Mn United States
Charterhouse
Discovery Postdoctoral Fellow
Novartis
Senior Research Associate
Deep Genomics